As the representative of fenamic acids, an important group of NSAIDs, flufenamic acid (FFA) has been used for anti-inflammation and analgesia in the clinic. Recently, researches have focused on the role of some members of NSAIDs in promoting osteogenesis. However, little attention has been paid to the subgroup of fenamic acids, and it remains unclear whether FFA and other fenamic acids could regulate mesenchymal stem cells’ (MSCs) lineage commitment and bone regeneration. Here we treated two kinds of human MSCs with FFA at different concentrations in vitro and examined the effect of FFA on osteogenic differentiation of human MSCs. This was followed by heterotopic bone formation assay in nude mice. In addition, ovariectomized and aged mice were used as osteoporotic models to test the effect of FFA on osteoporosis. Besides, activators and inhibitor of nuclear factor-κB (NF-κB) signaling pathway and western blot were used to clarify the mechanism of the promoting effect of low concentration FFA on osteogenesis. Our results indicated that low concentrations of FFA could significantly enhance osteogenic differentiation of human MSCs in vitro, as well as in vivo. In addition, FFA treatment suppressed bone loss in ovariectomized and aged mice. Mechanistically, FFA at low concentrations promoted osteogenesis differentiation of human MSCs by inhibition of the NF-κB signaling pathway. Collectively, our study suggested that low concentration FFA could be used in bone tissue engineering or osteoporosis by promoting osteogenic differentiation of human MSCs.
There is currently increasing focus on aging-related diseases. Osteoporosis is a common disease the incidence of which increases with age. In older patients with osteoporosis, bone marrow mesenchymal stem cells (BMMSCs) have a decreased capacity for osteogenesis and an increased capacity for adipogenesis, causing excessive accumulation of adipose tissue in the bone marrow. Therefore, means of reducing bone marrow adiposity may have therapeutic potential for osteoporosis. Apoptotic vesicles (apoVs) participate in a wide range of physiological processes and have been shown to have therapeutic effects in a variety of diseases. The principal objective of this study was to examine the special properties and regulatory mechanisms of BMMSC-derived apoVs in the treatment of bone marrow adiposity. The results showed that apoVs could decrease bone marrow adiposity in osteoporotic mice and prevent adipogenic differentiation of MSCs by activating the Wnt/β-catenin pathway. New apoV-based therapies have potential for the treatment of bone marrow adiposity in patients with aging-related osteoporosis and may be further applicable to the treatment of obesity and aging-related diseases.
13 April 2023 in Journal of Stomatology Oral and Maxillofacial Surgery
Background: This study aimed to develop and evaluate a deep learning (DL) algorithm based on magnetic resonance imaging (MRI) for the classification of temporomandibular joint degenerative joint disease (TMJDJD), thereby exploring its potential role in assisting cone-beam computed tomography (CBCT) examinations and minimizing patient radiation exposure. Methods: A retrospective analysis was conducted on 104 patients who had undergone both MRI and CBCT examinations of the temporomandibular joint. A total of 1769 sagittal and 1448 coronal MRI images were collected. After image preprocessing, the datasets were grouped according to different imaging features. Three DL frameworks—ResNet101, DenseNet201, and MobileNetV2—were developed to classify TMJDJD using various MRI image categories. The classification performance of these models was evaluated using accuracy, precision, recall, F1 score, Matthews correlation coefficient (MCC), and the results were compared with classifications made by two senior clinical experts in a blinded image-level reader experiment. Results: DenseNet201 achieved the best performance in the sagittal (Sg) group, with an accuracy of 80.11%, precision of 80.26%, recall of 75.31%, and an MCC of 0.60. DenseNet201 achieved the best performance among the evaluated DL models, with higher overall performance metrics than ResNet101 and MobileNetV2. In a constrained image-level reader comparison, DenseNet201 demonstrated comparable overall agreement metrics to the two experts, although one expert achieved higher recall and a lower false-negative rate. t-Distributed Stochastic Neighbor Embedding (t-SNE) and training curve analyses confirmed that DenseNet201 demonstrated superior feature extraction capability and a more stable training process. Grouping MRI images, however, did not improve model accuracy. Conclusions: DenseNet201 showed preliminary potential for MRI-based TMJDJD classification, particularly on sagittal images. Based on image-level classification results, the model may provide preliminary support for identifying MRI findings associated with TMJDJD and assisting decisions regarding further CBCT evaluation.